-
1
-
-
84870804978
-
-
European AIDS Clinical Society, [Accessed 30 October 2011]
-
European AIDS Clinical Society. Guidelines Version 6. http://europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/eacsguidelines- 6. Df. [Accessed 30 October 2011].
-
Guidelines Version 6.
-
-
-
2
-
-
77954692660
-
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel
-
Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-333.
-
(2010)
JAMA
, vol.304
, pp. 321-333
-
-
Thompson, M.A.1
Aberg, J.A.2
Cahn, P.3
Montaner, J.S.4
Rizzardini, G.5
Telenti, A.6
-
3
-
-
0034457885
-
HIV protease inhibitor-related lipodystrophy syndrome
-
Carr A. HIV protease inhibitor-related lipodystrophy syndrome. Clin Infect Dis 2000; 30 (Suppl 2):S135-S142.
-
(2000)
Clin Infect Dis
, vol.30
, Issue.SUPPL. 2
-
-
Carr, A.1
-
4
-
-
0037032941
-
Increased risk of lipoatrophy under stavudine in HIV-1- infected patients: Results of a substudy from a comparative trial
-
Joly V, Flandre P, Meiffredy V, Leturque N, Harel M, Aboulker JP, et al. Increased risk of lipoatrophy under stavudine in HIV-1- infected patients: results of a substudy from a comparative trial. AIDS 2002; 16:2447-2454.
-
(2002)
AIDS
, vol.16
, pp. 2447-2454
-
-
Joly, V.1
Flandre, P.2
Meiffredy, V.3
Leturque, N.4
Harel, M.5
Aboulker, J.P.6
-
6
-
-
2042439088
-
Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy
-
Hammond E, Nolan D, James I, Metcalf C, Mallal S. Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy. AIDS 2004; 18:815-817.
-
(2004)
AIDS
, vol.18
, pp. 815-817
-
-
Hammond, E.1
Nolan, D.2
James, I.3
Metcalf, C.4
Mallal, S.5
-
7
-
-
49949117158
-
Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection
-
McComsey GA, Libutti DE, Oriordan M, Shelton JM, Storer N, Ganz J, et al. Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection. Antivir Ther 2008; 13:715-722.
-
(2008)
Antivir Ther
, vol.13
, pp. 715-722
-
-
McComsey, G.A.1
Libutti, D.E.2
Oriordan, M.3
Shelton, J.M.4
Storer, N.5
Ganz, J.6
-
8
-
-
80052099398
-
Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy
-
Sevastianova K, Sutinen J, Greco D, Sievers M, Salmenkivi K, Perttila J, et al. Comparison of dorsocervical with abdominal subcutaneous adipose tissue in patients with and without antiretroviral therapy-associated lipodystrophy. Diabetes 2011; 60:1894-1900.
-
(2011)
Diabetes
, vol.60
, pp. 1894-1900
-
-
Sevastianova, K.1
Sutinen, J.2
Greco, D.3
Sievers, M.4
Salmenkivi, K.5
Perttila, J.6
-
9
-
-
0037999080
-
Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy
-
Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, et al. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy. AIDS 2003; 17:1329- 1338.
-
(2003)
AIDS
, vol.17
, pp. 1329-1338
-
-
Nolan, D.1
Hammond, E.2
Martin, A.3
Taylor, L.4
Herrmann, S.5
McKinnon, E.6
-
10
-
-
0035964717
-
Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy
-
Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S, et al. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 2001; 15:1801-1809.
-
(2001)
AIDS
, vol.15
, pp. 1801-1809
-
-
Shikuma, C.M.1
Hu, N.2
Milne, C.3
Yost, F.4
Waslien, C.5
Shimizu, S.6
-
11
-
-
7644244886
-
Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: A randomized, double-blind, placebo-controlled pilot study
-
Rabing Christensen E, Stegger M, Jensen-Fangel S, Laursen AL, Ostergaard L. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study. Clin Infect Dis 2004; 39:1371-1379.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 1371-1379
-
-
Rabing Christensen, E.1
Stegger, M.2
Jensen-Fangel, S.3
Laursen, A.L.4
Ostergaard, L.5
-
12
-
-
3042734983
-
Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy
-
van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck- Smit B, Hulsebosch HJ, et al. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. Antivir Ther 2004; 9:385-393.
-
(2004)
Antivir Ther
, vol.9
, pp. 385-393
-
-
Van Der Valk, M.1
Casula, M.2
Weverlingz, G.J.3
Van Kuijk, K.4
Van Eck- Smit, B.5
Hulsebosch, H.J.6
-
13
-
-
33748103186
-
Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
-
Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Antivir Ther 2006; 11:601-608.
-
(2006)
Antivir Ther
, vol.11
, pp. 601-608
-
-
Maagaard, A.1
Holberg-Petersen, M.2
Kollberg, G.3
Oldfors, A.4
Sandvik, L.5
Bruun, J.N.6
-
14
-
-
77949556554
-
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: Implications for the pathogenesis of the disease
-
Pinti M, Gibellini L, Guaraldi G, Orlando G, Gant TW, Morselli E, et al. Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease. AIDS 2010; 24:841-850.
-
(2010)
AIDS
, vol.24
, pp. 841-850
-
-
Pinti, M.1
Gibellini, L.2
Guaraldi, G.3
Orlando, G.4
Gant, T.W.5
Morselli, E.6
-
15
-
-
0032493043
-
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
-
Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998; 12:F51-F58.
-
(1998)
AIDS
, vol.12
-
-
Carr, A.1
Samaras, K.2
Burton, S.3
Law, M.4
Freund, J.5
Chisholm, D.J.6
-
16
-
-
0032537042
-
Indinavir-associated lipodystrophy
-
Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS 1998; 12:F37-F39.
-
(1998)
AIDS
, vol.12
-
-
Viraben, R.1
Aquilina, C.2
-
17
-
-
0033583977
-
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
-
Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 1999; 353:2093- 2099.
-
(1999)
Lancet
, vol.353
, pp. 2093-2099
-
-
Carr, A.1
Samaras, K.2
Thorisdottir, A.3
Kaufmann, G.R.4
Chisholm, D.J.5
Cooper, D.A.6
-
18
-
-
79957953991
-
Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines
-
Gallego-Escuredo JM, Del Mar Gutierrez M, Diaz-Delfin J, Domingo JC, Mateo MG, Domingo P, et al. Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines. Curr HIV Res 2010; 8:545-553.
-
(2010)
Curr HIV Res
, vol.8
, pp. 545-553
-
-
Gallego-Escuredo, J.M.1
Del Mar Gutierrez, M.2
Diaz-Delfin, J.3
Domingo, J.C.4
Mateo, M.G.5
Domingo, P.6
-
19
-
-
0034987343
-
The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance
-
Caron M, Auclair M, Vigouroux C, Glorian M, Forest C, Capeau J. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance. Diabetes 2001; 50:1378-1388.
-
(2001)
Diabetes
, vol.50
, pp. 1378-1388
-
-
Caron, M.1
Auclair, M.2
Vigouroux, C.3
Glorian, M.4
Forest, C.5
Capeau, J.6
-
20
-
-
0034731520
-
Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors
-
Dowell P, Flexner C, Kwiterovich PO, Lane MD. Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem 2000; 275:41325- 41332.
-
(2000)
J Biol Chem
, vol.275
, pp. 41325-41332
-
-
Dowell, P.1
Flexner, C.2
Kwiterovich, P.O.3
Lane, M.D.4
-
21
-
-
66249145434
-
Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss
-
van Vonderen MG, van Agtmael MA, Hassink EA, Milinkovic A, Brinkman K, Geerlings SE, et al. Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss. PLoS One 2009; 4:e5647.
-
(2009)
PLoS One
, vol.4
-
-
Van Vonderen, M.G.1
Van Agtmael, M.A.2
Hassink, E.A.3
Milinkovic, A.4
Brinkman, K.5
Geerlings, S.E.6
-
22
-
-
11144357775
-
Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a nonnucleoside reverse transcriptase inhibitor
-
Solas C, Poizot-Martin I, Drogoul MP, Ravaux I, Dhiver C, Lafeuillade A, et al. Therapeutic drug monitoring of lopinavir/ritonavir given alone or with a nonnucleoside reverse transcriptase inhibitor. Br J Clin Pharmacol 2004; 57:436-440.
-
(2004)
Br J Clin Pharmacol
, vol.57
, pp. 436-440
-
-
Solas, C.1
Poizot-Martin, I.2
Drogoul, M.P.3
Ravaux, I.4
Dhiver, C.5
Lafeuillade, A.6
-
23
-
-
20844435624
-
In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA
-
Mallon PW, Unemori P, Sedwell R, Morey A, Rafferty M, Williams K, et al. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis 2005; 191:1686-1696.
-
(2005)
J Infect Dis
, vol.191
, pp. 1686-1696
-
-
Mallon, P.W.1
Unemori, P.2
Sedwell, R.3
Morey, A.4
Rafferty, M.5
Williams, K.6
-
24
-
-
19944426227
-
Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine
-
McComsey GA, Paulsen DM, Lonergan JT, Hessenthaler SM, Hoppel CL, Williams VC, et al. Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS 2005; 19:15-23.
-
(2005)
AIDS
, vol.19
, pp. 15-23
-
-
McComsey, G.A.1
Paulsen, D.M.2
Lonergan, J.T.3
Hessenthaler, S.M.4
Hoppel, C.L.5
Williams, V.C.6
-
25
-
-
65749093276
-
Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovircontaining regimen
-
Gerschenson M, Kim C, Berzins B, Taiwo B, Libutti DE, Choi J, et al. Mitochondrial function, morphology and metabolic parameters improve after switching from stavudine to a tenofovircontaining regimen. J Antimicrob Chemother 2009; 63:1244- 1250.
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 1244-1250
-
-
Gerschenson, M.1
Kim, C.2
Berzins, B.3
Taiwo, B.4
Libutti, D.E.5
Choi, J.6
-
26
-
-
34250648975
-
Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults
-
Fleischman A, Johnsen S, Systrom DM, Hrovat M, Farrar CT, Frontera W, et al. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am J Physiol Endocrinol Metab 2007; 292:E1666-E1673.
-
(2007)
Am J Physiol Endocrinol Metab
, vol.292
-
-
Fleischman, A.1
Johnsen, S.2
Systrom, D.M.3
Hrovat, M.4
Farrar, C.T.5
Frontera, W.6
-
27
-
-
34548084819
-
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384
-
Dube MP, Komarow L, Mulligan K, Grinspoon SK, Parker RA, Robbins GK, et al. Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384. J Acquir Immune Defic Syndr 2007; 45: 508-514.
-
(2007)
J Acquir Immune Defic Syndr
, vol.45
, pp. 508-514
-
-
Dube, M.P.1
Komarow, L.2
Mulligan, K.3
Grinspoon, S.K.4
Parker, R.A.5
Robbins, G.K.6
-
28
-
-
0038708272
-
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
-
Mallon PW, Miller J, Cooper DA, Carr A. Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy. AIDS 2003; 17:971- 979.
-
(2003)
AIDS
, vol.17
, pp. 971-979
-
-
Mallon, P.W.1
Miller, J.2
Cooper, D.A.3
Carr, A.4
-
29
-
-
34447565930
-
Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen
-
Cameron DW, Becker S, King MS, da Silva B, Klein C, Tokimoto D, et al. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. J Antimicrob Chemother 2007; 59:957-963.
-
(2007)
J Antimicrob Chemother
, vol.59
, pp. 957-963
-
-
Cameron, D.W.1
Becker, S.2
King, M.S.3
Da Silva, B.4
Klein, C.5
Tokimoto, D.6
-
30
-
-
30444452551
-
In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis
-
Miro O, Villarroya J, Garrabou G, Lopez S, Rodriguez de la Concepcion M, Pedrol E, et al. In vivo effects of highly active antiretroviral therapies containing the protease inhibitor nelfinavir on mitochondrially driven apoptosis. Antivir Ther 2005; 10:945-951.
-
(2005)
Antivir Ther
, vol.10
, pp. 945-951
-
-
Miro, O.1
Villarroya, J.2
Garrabou, G.3
Lopez, S.4
De La Concepcion, M.R.5
Pedrol, E.6
-
31
-
-
3943095878
-
Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir
-
Hoy J, Gahan M, Carr A, Smith D, Lewin S, Wesselingh S, et al. Changes in mitochondrial DNA in peripheral blood mononuclear cells from HIV-infected patients with lipoatrophy randomized to receive abacavir. J Infect Dis 2004; 190:688- 692.
-
(2004)
J Infect Dis
, vol.190
, pp. 688-692
-
-
Hoy, J.1
Gahan, M.2
Carr, A.3
Smith, D.4
Lewin, S.5
Wesselingh, S.6
-
32
-
-
80054834564
-
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)
-
Feeney E, Chazallon C, O'Brien N, Meiffredy V, Goodall R, Aboulker JP, et al. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial). HIV Med 2011; 12:602-609.
-
(2011)
HIV Med
, vol.12
, pp. 602-609
-
-
Feeney, E.1
Chazallon, C.2
O'Brien, N.3
Meiffredy, V.4
Goodall, R.5
Aboulker, J.P.6
-
33
-
-
37349070983
-
Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: Preliminary results from a large randomized clinical trial
-
Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, et al. Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. J Acquir Immune Defic Syndr 2007; 46:318-322.
-
(2007)
J Acquir Immune Defic Syndr
, vol.46
, pp. 318-322
-
-
Wester, C.W.1
Okezie, O.A.2
Thomas, A.M.3
Bussmann, H.4
Moyo, S.5
Muzenda, T.6
-
34
-
-
0041914142
-
Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns
-
Galli M, Veglia F, Angarano G, Santambrogio S, Meneghini E, Gritti F, et al. Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr 2003; 34:58-61.
-
(2003)
J Acquir Immune Defic Syndr
, vol.34
, pp. 58-61
-
-
Galli, M.1
Veglia, F.2
Angarano, G.3
Santambrogio, S.4
Meneghini, E.5
Gritti, F.6
|